Next Article in Journal
The Influence of Radical Prostatectomy on the Expression of Cell-Free MiRNA
Next Article in Special Issue
New Approaches in the Study of the Pathogenesis of Urethral Pain Syndrome
Previous Article in Journal
Somatostatin Receptor PET/CT Imaging for the Detection and Staging of Pancreatic NET: A Systematic Review and Meta-Analysis
Previous Article in Special Issue
Identification of Human Ovarian Adenocarcinoma Cells with Cisplatin-Resistance by Feature Extraction of Gray Level Co-Occurrence Matrix Using Optical Images
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Design of Liver Functional Reserve Estimation Technique Based on Optical Densitometry

1
Institute of Physics, Nanotechnology and Telecommunications, Peter the Great St. Petersburg Polytechnic University, 195251 St. Petersburg, Russia
2
Department of Anesthesiology and Resuscitation Russian Research Center for Radiology and Surgical Technologies, 197758 St. Petersburg, Russia
3
Computer Information Systems, International University of Kyrgyzstan, Bishkek 720007, Kyrgyzstan
*
Author to whom correspondence should be addressed.
Diagnostics 2020, 10(8), 599; https://doi.org/10.3390/diagnostics10080599
Submission received: 14 July 2020 / Revised: 11 August 2020 / Accepted: 13 August 2020 / Published: 16 August 2020
(This article belongs to the Special Issue Optical Diagnostics in Human Diseases)

Abstract

:
This work is aimed at creating a modified invasive technique for assessing the liver’s functional reserves. A study of the degree of hepatodepression is carried out by measuring the plasma elimination of indocyanine green using the method of optical densitometry. This paper presents test results for an aqueous solution and an albumin solution, as well as the results of measurements of plasma elimination of indocyanine green for patients with liver disease. Perfecting the proposed method will make an important scientific contribution to modern diagnostic medicine. Diagnosing the stages in the progression of the disease and its developing complications can make it possible to rapidly correct the patient’s treatment algorithm, achieving positive outcomes in medical practice.

1. Introduction

One of the pressing issues in modern hepatology is assessing the degree of hepatic depression [1,2,3,4,5]. As of 2019, 325 million people worldwide have been infected with viral hepatitis B or C, and 1.4 million people die from it every year, while the need for resection occurs in 80% of cases in patients with hepatitis C and B [2].
Liver disease can be divided into diffuse and focal. The underlying pathophysiological mechanisms of the progression of diffuse liver disease are inflammation, vascular insufficiency, or abnormal accumulation of substances. Chronic liver failure is most frequently caused by viral hepatitis and fatty degeneration of hepatocytes of alimentary origin. Fulminant liver failure is mainly caused by hepatitis viruses and xenobiotics (including drugs). Diffuse liver disease is traditionally treated by hepatologists. The progression of chronic liver failure naturally raises the question about a radical method of treatment that is liver transplantation. Unfortunately, the existing clinical criteria for prediction are not perfect, which means that patients are not placed on the waiting list for transplantation in a timely manner. In the case of focal lesions (primary tumor, metastases, parasitic cyst, and abscess), the surgical strategy consists of removing pathological lesions while ensuring sufficient function of remaining organ volume. Experimental data indicate that the mass of liver tissue sufficient to meet the needs of the body is about 1% of body weight. However, this refers to fully functional tissue. In case of combined focal and diffuse lesions, such estimates will be low. Another branch of medicine where functional assessment of the liver plays a crucial role is treatment of organ failure in patients in critical condition. It is known that the hepatic component is the most difficult to control.
The study of the functional status of the liver currently includes the parameters of synthesis (prothrombin, cholesterol, and albumin), cellular integrity (transaminase), detoxification (ammonia) excretion, and cholestasis (bilirubin, alkaline phosphatase, and gamma-glutamyl transpeptidase) in combination with various imaging techniques. These “static” tests of hepatic function have limitations, especially when it comes to prognosis of survival or liver function tests in patients in critical condition [6]. Currently, only dynamic tests based on studies of the clearance of exogenously introduced substances can give a global picture of organ function [7]. Some tests can be used repeatedly within a limited time frame, for example, allowing to determine the limit of resection more thoroughly in conditions of temporary vascular isolation of the organ.
Dozens of substances were proposed as dynamic markers (both natural participants of metabolic reactions, and xenobiotics), along with methods for their detection. Only a few have reached widespread clinical use. One of the markers that has become firmly rooted in the practice of hepatology is indocyanine green (ICG) [8]. It is a water-soluble non-toxic fluorescent dye used for diagnostics of the cardiovascular system since 1956 [9]. After indocyanine green is administered intravenously, it is distributed only to the intravascularly space, binding to plasma proteins, and is removed from the blood only by hepatocytes. ICG refers to exogenous markers with rapid hepatic elimination, respectively, the rate of excretion depends on the function of hepatocytes and the hepatic blood flow rate.
The gold standard for determining the rate of ICG elimination is the method of sequential samples. Blood samples taken at regular intervals after the introduction of ICG are centrifuged, and the plasma is subjected to photometry (spectrophotometry) at a wavelength of 805 nm [10,11]. The disadvantages of sequential sampling are the long times it takes, and the additional personnel required. Thanks to the unique physical characteristics of indocyanine green, determination of ICG elimination rate by pulse densitometry was first introduced in the late 1990s. While a large number of publications confirm a high correlation of invasive and non-invasive techniques, there are certain problems related to pulse densitometry [10,11,12,13,14]. In particular, impaired capillary blood flow [15,16], obesity, and tremor of the extremities prevent obtaining reliable data [14]. This problem is especially important) in patients in critical condition. If non-invasive measurements fail, not only are expensive drugs lost, but new measurements are inevitably delayed to ensure that the previous dose of the indicator has been eliminated. Unfortunately, the technique for non-invasive determination of absolute ICG concentration and the related opportunities for calculating the circulating blood volume have also not been developed any further.
To solve this problem, we propose to use a combination of invasive and non-invasive methods for determining the rate of dye elimination on a single platform, with the possibility of post-processing the data obtained by pulse densitometry. The goal of this work is to develop the first stage, namely, an invasive method for measuring the plasma elimination of indocyanine green for diagnosing hepatic function.

2. Experimental Setup of Optical Densitometry

An experimental setup that we developed (Figure 1) was used to conduct measurements of plasma elimination of indocyanine green for diagnostics of hepatic function.
Light emitted from diode (1) passes though the test solution. Part of the radiation is absorbed, and part of the radiation is backscattered [17,18]. The emitting diode has an emission spectrum narrower than the peak absorption spectrum of the dye in the near infrared region; therefore, a monochromatic filter in the circuit is not required. The prepared solution of known concentration of indocyanine green is placed in cuvette (2). Photodetector (3) is used to detect the transmitted radiation. The distance between the emitting diode and the photodetector is 100 mm. Measured at this distance, the intensity of light passing through the cuvette with water without dye is 100 µW. The cuvette with the solution is placed 50 mm from the emitting diode. Measurements are made every 0.4 s.
Microcontroller (4) controls the collection of data by the Serial Peripheral Interface bus. The emitting diode is powered by the MCU pins and has only two modes: on and off. Communication with the photodetector is performed through the I2C interface. Data from the microcontroller for further processing are displayed on user device (5), which is a personal computer or an android device via USB.
The signal fluctuations of the medium optical density occur during the measurements. Their deviation from the average value, as a rule, does not reach 0.5% [19,20]. Fluctuations in optical density can be conditioned by fluctuations of dye concentration, intensity measurement error is mostly determined by photodetector quantization error. Figure 2 presents an example of the received signal.
The developed experimental setup has several advantages compared with other photometric methods.
  • Small dimension:
    The size of the experimental setup is 15 × 7 × 5 cm. The number of elements in this installation is minimized.
  • Noise immunity:
    To improve the noise immunity, the Butterworth low pass filter and median filter were used.
  • Cost-effectiveness:
    Optimized device design allows using cheaper optical elements. Emitting diode with 810 nm was used as a light source. (Which is cheaper than deuterium and tungsten sources)
  • Simplicity of use:
    This experimental setup does not require additional training of users for carrying out experimental studies.
  • Quick real-time presentation of the results:
    Processing of experimental studies takes up to several minutes.

3. Results and Discussion

This paper presents test measurements of the developed experimental setup and the proposed software. Solutions of the indocyanine green dye with water and with albumin were used as test samples.
At the first stage, measurements were made for an aqueous solution of indocyanine green at a low dye concentration. These samples were prepared by adding small portions of the dye with a known concentration in distilled water. Figure 3 shows a graph of the obtained experimental results for measuring the concentration of an aqueous solution of green indocyanine at a low dye concentration and their approximation by the exponent. The measurement result is calculated by averaging the signal values. The error bars marked on the graph reflect the value of the random experimental error calculated by estimation of the mean value (10 measurements), and confidence interval with a confidence level of 95%.
Measurements at a low dye concentration are approximated by an exponent with a selected coefficient.
To test the operability of the developed experimental setup, we also performed experiments for a 20% albumin solution, gradually adding the dye to the test medium. The experimental results of measurements with low concentrations of indocyanine green in a 20% albumin solution and their exponential approximation are presented in Figure 4.
An experiment with a 20% albumin solution in the dye concentration range showed agreement with the theoretical data. However, in contrast to the experiment with water, it was not possible to choose an exponent that could approximate the beginning of the graph at a concentration near zero.
At the second stage of the measurements, we studied blood plasma samples from patients with liver pathology. Plasma samples were taken from 23 patients with liver pathology as part of routine ICG serial blood testing at the department of anesthesiology and intensive care of Russian Research Center of Radiology and Surgical Technologies. Plasma samples form a series each consisting of a set of measurements during the study of one patient. We have studied the samples taken before administering the dye, which are used to determine the optical density of the blood plasma itself. The intensity I0 of the light passing through the plasma without dye allows to calculate the relative concentration of the dye in subsequent samples:
C r e l = ln ( I I 0 ) .
In addition, plasma samples taken 2, 7, 12, and 17 min after dye administration were investigated. Figure 5 shows the results for a plasma sample from one of the patients with liver pathology.
Experiments with plasma allowed us to estimate the rate of dye elimination in the blood of patients. By calculating the relative concentration of the dye in these samples and comparing them, we can estimate the PDR (plasma disappearance rate) parameter by approximating a series of concentrations with an exponent with a selected coefficient for the argument. Measurements of the concentration ratio in the samples taken after 2 and 17 min determine the value of the PDR parameter, defined as the percentage by which the dye concentration decreases in 15 min. Figure 6 presents the results of experiments with plasma aimed at assessing the rate of elimination of the dye in the blood of patients.
The metabolic function of the liver of patients can be assessed based on these results. The faster the liver removes the dye from the circulatory system, the lower the ratio of the concentration in the subsequent sample to the concentration in the previous one after the same period. The liver of those patients whose curves are located lower purifies the blood better than the liver of those whose curves are higher.
To compare the results obtained by evaluating the concentration of the dye in the plasma, parallel studies were carried out by the method of sequential sampling on a commercial DU® 800 UV/Visible Spectrophotometer. Figure 7 shows the relationship between the optical densities of the samples measured using a spectrophotometer (D2) and the optical densities of the samples measured using our experimental setup (D1).
PDR values were also calculated by two methods. The comparison of the results is shown in Figure 8.
Figure 7 and Figure 8 show that there is a correlation between the two measurement methods. The preliminary results obtained for assessing the concentration of indocyanine green in various liquids can be the basis for further studies [21]. This development can be included in the smart medical autonomous distributed system for diagnostics based on machine learning technology [22].

4. Conclusions

In this study, we developed an experimental setup, a program for collecting and displaying data, and an experimental technique for assessing the concentration of green indocyanine in various solutions. The experimental studies involved measurements with an aqueous dye, an albumin solution, and blood plasma correlated with the data from a commercial DU® 800 UV/Visible spectrophotometer. The main (advantages) of a device are cost-effectiveness, simplicity of use and quick real-time presentation of the results. The developed system will make it possible to diagnose liver function and predict its recovery with higher accuracy compared with existing approaches.

Author Contributions

Funding acquisition, supervision, E.V.; methodology, formal analysis, V.O.; investigation, I.K.; experiment in Russian Research Center for Radiology and Surgical Technologies, L.K.; writing—original draft preparation, E.S. and I.K.; and machine learning consultation and data evaluation, Z.M. All authors have read and agreed to the published version of the manuscript.

Funding

This research work was supported by Peter the Great St. Petersburg Polytechnic University in the framework of the Program “5-100-2020”.

Acknowledgments

We express our gratitude to the Russian Research Center for Radiology and Surgical Technologies for providing biological samples, to S.V. Ermak for comprehensive assistance and valuable scientific advice, and to E.K. Nepomnyashchaya for illustration design.

Conflicts of Interest

The authors declare no conflict of interest. The funders/sponsors had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

References

  1. Rosen, H.R. Chronic hepatitis C infection. N. Engl. J. Med. 2011, 364, 2429–2438. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. World Health Organization. Available online: https://www.who.int/campaigns/world-hepatitis-day/2019 (accessed on 3 July 2020).
  3. Williamson, R.M.; Price, J.F.; Glancy, S.; Perry, E.; Nee, L.D.; Hayes, P.C. Prevalence of and risk factors for hepatic steatosis and nonalcoholic fatty liver disease in people with type 2 diabetes: The Edinburgh Type 2 Diabetes Study. Diabetes Care 2011, 34, 1139–1144. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Aijaz, A.; Perumpail, R.B.; Harrison, S.A. High prevalence of hepatic fibrosis in the setting of coexisting diabetes and hepatic steatosis: A case for selective screening in the general population? Hepatology 2016, 63, 20–22. [Google Scholar]
  5. Mueller, A.R.; Platz, K.P.; Kremer, B. Early postoperative complications following liver transplantation. Best Pract. Res. Clin. Gastroenterol. 2004, 18, 881–900. [Google Scholar] [CrossRef]
  6. Bonfrate, L.; Grattagliano, I.; Palasciano, G.; Portincasa, P. Dynamic carbon 13 breath tests for the study of liver function and gastric emptying. Gastroenterol. Rep. 2014, 3, 12–21. [Google Scholar] [CrossRef] [PubMed]
  7. Sakka, S.G. Assessing liver function. Curr. Opin. Crit. Care 2007, 13, 207–214. [Google Scholar] [CrossRef] [PubMed]
  8. Kunikowska, A.J.; Wildgruber, M.; Schulte-Frohlinde, E.; Lahmer, T.; Schmid, R.M.; Huber, W. Liver function assessment using indocyanine green plasma disappearance rate in a young male with icteric leptospirosis: A case report. BMC Infect. Dis. 2019, 19, 473. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  9. Slakter, J.S.; Yannuzzi, L.A.; Guyer, D.R.; Sorenson, J.A.; Orlock, D.A. Indocyanine-green angiography. Curr. Opin. Ophthalmol. 1995, 6, 25–32. [Google Scholar] [CrossRef] [PubMed]
  10. Haruna, M.; Kumon, K.; Yahagi, N.; Watanabe, Y.; Ishida, Y.; Kobayashi, T.; Aoyagi, T. Blood Volume Measurement at the Bedside Using ICG Pulse Spectrophometry. Anesthesiology 1998, 89, 1322–1328. [Google Scholar] [CrossRef] [PubMed]
  11. Osamu, O.; Tetsuya, K.; Hiroyuki, S.; Soichiro, I.; Shin, T.; Akimasa, N. ICG Pulse Spectrophotometry for Perioperative Liver Function in Hepatectomy. J. Surg. Res. 2002, 103, 109–113. [Google Scholar]
  12. Kovac, N.; Peric, M. Liver function assessment by indocyanine green plasma disappearance rate in patients with intra-abdominal hypertension after “non-hepatic” abdominal surgery. Curr. Med. Res. Opin. 2018, 34, 1741–1746. [Google Scholar] [CrossRef] [PubMed]
  13. Mayr, U.; Fahrenkrog-Petersen, L.; Batres-Baires, G.; Herner, A.; Rasch, S.; Schmid, R.M.; Lahmer, T. Largevolume paracentesis effects plasma disappearance rate of indocyanine green in critically ill patients with decompensated liver cirrhosis and intraabdominal hypertension. Ann. Intensive Care 2018, 8, 1–10. [Google Scholar]
  14. Pantanali, C.A.; Gonzalez, D.E.; D’Albuquerque, L.A.; Andraus, W.; Barzallo, P.; Asperti, A.M. Lessons Learned with the LiMON Method of Indocyanine Green Elimination. EC Gastroenterol. Dig. Syst. 2018, 5, 297–304. [Google Scholar]
  15. Li, H.-m. Microcirculation of liver cancer, microenvironment of liver regeneration, and the strategy of Chinese medicine. Chin. J. Integr. Med. 2016, 22, 163–167. [Google Scholar] [CrossRef] [PubMed]
  16. Tian, H.; Qi, W. Quantitative analysis of microcirculation blood perfusion in patients with hepatocellular carcinoma before and after transcatheter arterial chemoembolisation using contrast-enhanced ultrasound. Eur. J. Cancer 2016, 68, 82–89. [Google Scholar] [CrossRef] [PubMed]
  17. Davydov, R.V.; Antonov, V.I.; Yushkova, V.V.; Grebenikova, N.M.; Dudkin, V.I. A new algorithm for processing the absorption and scattering signals of laser radiation on a blood vessel and human tissues. J. Phys. Conf. Ser. 2019, 1236, 012079. [Google Scholar] [CrossRef]
  18. Bisyarin, M.A.; Kotov, O.I.; Hartog, A.H.; Liokumovich, L.B.; Ushakov, N.A. Influence of a variable Rayleigh scattering-loss coefficient on the light backscattering in multimode optical fibers. Appl. Opt. 2017, 56, 4629. [Google Scholar] [CrossRef] [PubMed]
  19. Kotov, O.; Chapalo, I. Signal-to-noise ratio for mode-mode fiber interferometer. In Optical Measurement Systems for Industrial Inspection X; SPIE Optical Metrology: Munich, Germany, 2017. [Google Scholar]
  20. Liokumovich, L.B.; Kostromitin, A.O.; Ushakov, N.A.; Kudryashov, A.V. Method for Measuring Laser Frequency Noise. J. Appl. Spectrosc. 2020, 86, 1106–1112. [Google Scholar] [CrossRef]
  21. Privalov, V.E.; Rybalko, A.V.; Charty, P.V.; Shemanin, V.G. Effect of noise and vibration on the performance of a particle concentration laser meter and optimization of its parameters. Tech. Phys. 2007, 52, 352–355. [Google Scholar] [CrossRef]
  22. Velichko, E.; Nepomnyashchaya, E.; Baranov, M.; Galeeva, M.A.; Pavlov, V.A.; Zavjalov, S.V.; Savchenko, E.; Pervunina, T.M.; Govorov, I.; Komlichenko, E. A Concept of Smart Medical Autonomous Distributed System for Diagnostics Based on Machine Learning Technology. In Internet of Things, Smart Spaces, and Next Generation Networks and Systems; Springer: Cham, Switzerland, 2019; pp. 515–524. [Google Scholar]
Figure 1. Experimental setup: (1) emitting diode, (2) sample cell, (3) photodetector, (4) microcontroller, and (5) computer.
Figure 1. Experimental setup: (1) emitting diode, (2) sample cell, (3) photodetector, (4) microcontroller, and (5) computer.
Diagnostics 10 00599 g001
Figure 2. Example of time dependence of intensity of the light transmitted by 20% albumin solution without dye: I–the intensity of the light transmitted, t–recording time of the signal.
Figure 2. Example of time dependence of intensity of the light transmitted by 20% albumin solution without dye: I–the intensity of the light transmitted, t–recording time of the signal.
Diagnostics 10 00599 g002
Figure 3. Ratio of intensity (I) of the light transmitted by aqueous solution of green indocyanine at low dye concentration (C) to intensity (I0) of the light transmitted by water, and its approximation by an exponential function (exp).
Figure 3. Ratio of intensity (I) of the light transmitted by aqueous solution of green indocyanine at low dye concentration (C) to intensity (I0) of the light transmitted by water, and its approximation by an exponential function (exp).
Diagnostics 10 00599 g003
Figure 4. Ratio of the intensity of the light transmitted by dye albumin solution to intensity of light transmitted by solution of albumin and its approximation by an exponential function.
Figure 4. Ratio of the intensity of the light transmitted by dye albumin solution to intensity of light transmitted by solution of albumin and its approximation by an exponential function.
Diagnostics 10 00599 g004
Figure 5. Ratio of intensity of the light transmitted by the dye blood plasma solution to the intensity of light transmitted by blood plasma solution from the time the plasma was taken from the patient.
Figure 5. Ratio of intensity of the light transmitted by the dye blood plasma solution to the intensity of light transmitted by blood plasma solution from the time the plasma was taken from the patient.
Diagnostics 10 00599 g005
Figure 6. Plasma dye elimination curves corresponding to individual series.
Figure 6. Plasma dye elimination curves corresponding to individual series.
Diagnostics 10 00599 g006
Figure 7. Comparison of the optical densities, D, obtained by two methods: D2–the optical densities of the samples measured using a spectrophotometer and D1–the optical densities of the samples measured using our experimental setup.
Figure 7. Comparison of the optical densities, D, obtained by two methods: D2–the optical densities of the samples measured using a spectrophotometer and D1–the optical densities of the samples measured using our experimental setup.
Diagnostics 10 00599 g007
Figure 8. Comparison of plasma disappearance rate (PDR) parameters calculated from the measurements obtained with DU® 800 UV/Visible Spectrophotometer at the Department of Anesthesiology and Intensive Care of Russian Research Center for Radiology and Surgical Technologies (PDR2), and with our experimental setup (PDR1).
Figure 8. Comparison of plasma disappearance rate (PDR) parameters calculated from the measurements obtained with DU® 800 UV/Visible Spectrophotometer at the Department of Anesthesiology and Intensive Care of Russian Research Center for Radiology and Surgical Technologies (PDR2), and with our experimental setup (PDR1).
Diagnostics 10 00599 g008

Share and Cite

MDPI and ACS Style

Savchenko, E.; Kolokolnikov, I.; Velichko, E.; Osovskikh, V.; Kiseleva, L.; Musakulova, Z. Design of Liver Functional Reserve Estimation Technique Based on Optical Densitometry. Diagnostics 2020, 10, 599. https://doi.org/10.3390/diagnostics10080599

AMA Style

Savchenko E, Kolokolnikov I, Velichko E, Osovskikh V, Kiseleva L, Musakulova Z. Design of Liver Functional Reserve Estimation Technique Based on Optical Densitometry. Diagnostics. 2020; 10(8):599. https://doi.org/10.3390/diagnostics10080599

Chicago/Turabian Style

Savchenko, Ekaterina, Ilya Kolokolnikov, Elena Velichko, Victor Osovskikh, Lyubov Kiseleva, and Zhyldyz Musakulova. 2020. "Design of Liver Functional Reserve Estimation Technique Based on Optical Densitometry" Diagnostics 10, no. 8: 599. https://doi.org/10.3390/diagnostics10080599

APA Style

Savchenko, E., Kolokolnikov, I., Velichko, E., Osovskikh, V., Kiseleva, L., & Musakulova, Z. (2020). Design of Liver Functional Reserve Estimation Technique Based on Optical Densitometry. Diagnostics, 10(8), 599. https://doi.org/10.3390/diagnostics10080599

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop